Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis presenting with progressive visual failure.

I E Ormerod, W I McDonald

    Journal of Neurology, Neurosurgery, and Psychiatry
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysis.

    European journal of neurology·2013
    Same author

    High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.

    Journal of neurology·2003
    Same author

    [Diagnosis of multiple sclerosis].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2003
    Same author

    Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

    Annals of neurology·2001
    Same author

    Very late onset Friedreich's presenting as spastic tetraparesis without ataxia or neuropathy.

    Neurology·2001
    Same author

    T cell lymphocytosis associated with polymyositis, myasthenia gravis and thymoma.

    Clinical and laboratory haematology·2000
    Same journal

    Global epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

    Journal of neurology, neurosurgery, and psychiatry·2026
    See all related articles

    Progressive visual failure can be the first sign of multiple sclerosis (MS). Cerebrospinal fluid oligoclonal bands suggest MS but require further tests to rule out other treatable causes of vision loss.

    Area of Science:

    • Neuro-ophthalmology
    • Neurology
    • Immunology

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
    • Visual impairment is a common initial symptom in MS, but its presentation can be varied.
    • Distinguishing MS-related visual loss from other optic neuropathies is crucial for timely diagnosis and management.

    Observation:

    • Five patients presented with progressive visual failure as the primary symptom of multiple sclerosis.
    • Clinical presentation of these cases mimicked visual loss caused by optic nerve compression.
    • Cerebrospinal fluid (CSF) analysis revealed oligoclonal bands in all presenting patients.

    Findings:

    • The presence of oligoclonal bands in CSF is a valuable diagnostic indicator for MS.

    Related Experiment Videos

  • However, oligoclonal bands are not pathognomonic for MS and can be found in other neurological conditions.
  • Clinical features alone were insufficient to differentiate MS-induced visual loss from compressive etiologies.

    • Implications:

    • Early identification of MS is critical for initiating disease-modifying therapies.
    • Comprehensive diagnostic workup is essential to exclude other treatable causes of visual impairment.
    • This highlights the importance of considering MS in patients with unexplained progressive vision loss, even with atypical presentations.